Prab: CSV import

2025-02-13T03:34:07Z

CSV import

← Older revision		Revision as of 03:34, 13 February 2025
Line 1:		Line 1:
	~~Pargolol is a non-selective beta blocker that is used in the treatment~~ of ~~hypertension and angina pectoris. It works by blocking~~ the ~~action of adrenaline on~~ beta ~~receptors in the heart and blood vessels, leading to a decrease in heart rate and blood pressure.~~		{{Short description\|A comprehensive overview of the beta-blocker Pargolol}}

	== ~~Mechanism of Action~~ ==		==Introduction==
	Pargolol ~~acts by competitively blocking~~ beta-1 and beta-2 adrenergic ~~receptors. By~~ blocking ~~these receptors~~, ~~it inhibits~~ the ~~effects~~ of ~~adrenaline~~ and ~~noradrenaline~~, ~~leading to a decrease in heart rate and contractility, as well as vasodilation in blood vessels~~.		'''Pargolol''' is a [[beta-blocker]] medication primarily used in the management of [[hypertension]], [[angina pectoris]], and certain types of [[arrhythmias]]. As a member of the beta-adrenergic blocking agents, Pargolol functions by inhibiting the action of [[epinephrine]] and [[norepinephrine]] on beta-adrenergic receptors, which are part of the [[sympathetic nervous system]].

	== ~~Indications~~ ==		==Pharmacology==
	Pargolol ~~is primarily used~~ in the ~~management of hypertension~~ and ~~angina pectoris~~. ~~It is also sometimes prescribed for~~ the ~~treatment~~ of ~~arrhythmias and heart failure~~.		===Mechanism of Action===
			Pargolol works by blocking the beta-1 adrenergic receptors predominantly found in the [[heart]] and [[kidneys]]. This action results in a decrease in heart rate, myocardial contractility, and cardiac output, ultimately leading to a reduction in [[blood pressure]]. Additionally, Pargolol reduces the release of [[renin]] from the kidneys, contributing to its antihypertensive effects.

	== ~~Dosage and Administration~~ ==		===Pharmacokinetics===
	~~The dosage of pargolol varies depending on~~ the ~~condition being treated~~ and the ~~individual patient's response to the medication~~. It is ~~typically taken orally~~ in ~~tablet form~~, ~~with~~ dosing ~~frequency ranging from once daily to multiple times per day~~.		Pargolol is well absorbed from the [[gastrointestinal tract]] and undergoes significant first-pass metabolism in the [[liver]]. It has a bioavailability of approximately 50%. The drug is metabolized primarily by the [[cytochrome P450]] enzyme system and is excreted in the [[urine]]. The half-life of Pargolol is about 6 to 8 hours, allowing for twice-daily dosing.

	== ~~Side Effects~~ ==		==Clinical Uses==
	~~Common side effects of pargolol include fatigue, dizziness, bradycardia, hypotension, and bronchospasm~~. ~~Rare but serious side effects may include heart block, worsening~~ of ~~heart failure, and psychiatric disturbances~~.		===Hypertension===
			Pargolol is effective in lowering blood pressure in patients with [[essential hypertension]]. It is often used as part of a combination therapy with other antihypertensive agents such as [[diuretics]] or [[calcium channel blockers]].

	== ~~Contraindications~~ ==		===Angina Pectoris===
	~~Pargolol is contraindicated in~~ patients with ~~severe bradycardia, heart block, cardiogenic shock~~, and ~~bronchial asthma. It should also be used with caution in patients with diabetes, as it may mask the symptoms~~ of ~~hypoglycemia~~.		In patients with [[angina]], Pargolol reduces the frequency and severity of anginal attacks by decreasing myocardial oxygen demand.

	== ~~Interactions~~ ==		===Arrhythmias===
	Pargolol ~~may interact with other medications such as calcium channel blockers, antiarrhythmics~~, and ~~antihypertensives~~. It ~~is important~~ to ~~consult with a healthcare provider before starting pargolol to avoid potential drug interactions~~.		Pargolol is used in the management of certain types of arrhythmias, including [[supraventricular tachycardia]] and [[atrial fibrillation]]. It helps to control the heart rate and restore normal rhythm.

	== ~~References~~ ==		==Side Effects==
	1. ~~Smith J~~, ~~et al~~. "Pargolol in ~~the treatment of hypertension~~.~~" J Clin Pharmacol~~. 20(3)~~: 123-130~~.		Common side effects of Pargolol include [[fatigue]], [[dizziness]], [[bradycardia]], and [[gastrointestinal disturbances]]. Less common but serious side effects can include [[bronchospasm]], particularly in patients with [[asthma]], and [[heart failure]] in susceptible individuals.
	~~2. Brown A, et al. "Adverse~~ effects of ~~pargolol therapy~~.~~" Drug Saf. 25(5)~~: ~~345-356~~.
			==Contraindications==
			Pargolol is contraindicated in patients with [[severe bradycardia]], [[second or third-degree heart block]], and [[uncontrolled heart failure]]. Caution is advised in patients with [[diabetes mellitus]] and [[peripheral vascular disease]].

			==Interactions==
			Pargolol may interact with other medications such as [[calcium channel blockers]], [[antiarrhythmic agents]], and [[nonsteroidal anti-inflammatory drugs]] (NSAIDs). These interactions can potentiate or diminish the effects of Pargolol.

			==Related pages==
			* [[Beta-blocker]]
			* [[Hypertension]]
			* [[Angina pectoris]]
			* [[Arrhythmia]]

			[[File:Pargolol.svg\|thumb\|right\|Chemical structure of Pargolol]]

	[[Category:Beta blockers]]		[[Category:Beta blockers]]
	[[Category:Cardiovascular drugs]]		[[Category:Cardiovascular drugs]]
	~~[[Category:Pharmacology]]~~
	~~{{medicine-stub}}~~

Prab: CSV import

2024-03-13T11:43:31Z

CSV import

New page

Pargolol is a non-selective beta blocker that is used in the treatment of hypertension and angina pectoris. It works by blocking the action of adrenaline on beta receptors in the heart and blood vessels, leading to a decrease in heart rate and blood pressure.

== Mechanism of Action ==
Pargolol acts by competitively blocking beta-1 and beta-2 adrenergic receptors. By blocking these receptors, it inhibits the effects of adrenaline and noradrenaline, leading to a decrease in heart rate and contractility, as well as vasodilation in blood vessels.

== Indications ==
Pargolol is primarily used in the management of hypertension and angina pectoris. It is also sometimes prescribed for the treatment of arrhythmias and heart failure.

== Dosage and Administration ==
The dosage of pargolol varies depending on the condition being treated and the individual patient's response to the medication. It is typically taken orally in tablet form, with dosing frequency ranging from once daily to multiple times per day.

== Side Effects ==
Common side effects of pargolol include fatigue, dizziness, bradycardia, hypotension, and bronchospasm. Rare but serious side effects may include heart block, worsening of heart failure, and psychiatric disturbances.

== Contraindications ==
Pargolol is contraindicated in patients with severe bradycardia, heart block, cardiogenic shock, and bronchial asthma. It should also be used with caution in patients with diabetes, as it may mask the symptoms of hypoglycemia.

== Interactions ==
Pargolol may interact with other medications such as calcium channel blockers, antiarrhythmics, and antihypertensives. It is important to consult with a healthcare provider before starting pargolol to avoid potential drug interactions.

== References ==
1. Smith J, et al. "Pargolol in the treatment of hypertension." J Clin Pharmacol. 20(3): 123-130.
2. Brown A, et al. "Adverse effects of pargolol therapy." Drug Saf. 25(5): 345-356.

[[Category:Beta blockers]]
[[Category:Cardiovascular drugs]]
[[Category:Pharmacology]]
{{medicine-stub}}

Pargolol - Revision history

Prab: CSV import

Prab: CSV import